Physicochemical Properties
| Molecular Formula | C17H11F8N3O4 |
| Molecular Weight | 473.274172067642 |
| Exact Mass | 473.062 |
| CAS # | 1236767-85-3 |
| PubChem CID | 59416313 |
| Appearance | Pale purple to purple solid powder |
| LogP | 3.4 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 6 |
| Heavy Atom Count | 32 |
| Complexity | 829 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | FC(C(F)(F)F)(COC1=NC2=C(C(N1C1C=CC(=CC=1)OCC(F)(F)F)=O)CC(N2)=O)F |
| InChi Key | NGUQGJZXDBRNOL-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C17H11F8N3O4/c18-15(19,17(23,24)25)6-32-14-27-12-10(5-11(29)26-12)13(30)28(14)8-1-3-9(4-2-8)31-7-16(20,21)22/h1-4H,5-7H2,(H,26,29) |
| Chemical Name | 2-(2,2,3,3,3-pentafluoropropoxy)-3-[4-(2,2,2-trifluoroethoxy)phenyl]-5,7-dihydropyrrolo[2,3-d]pyrimidine-4,6-dione |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | In enzymatic and cellular studies, D5D-IN-326 is a selective and potent oral delta-5 desaturase (D5D) inhibitor, with IC50 values of 72 and 22 nM for rat and human D5D, respectively, and for D6D or D9D. Exercise has no impact [1]. |
| ln Vivo | When given orally for six weeks, D5D-IN-326 (0.1, 1 and 10 mg/kg) progressively decreased body weight at the 10 mg/kg dose; however, in DIO mice, lesser doses were ineffective after six weeks of treatment [1]. Additionally, D5D-IN-326 (10 mg/kg, orally administered for 6 weeks) dramatically decreased the levels of Ccl2, Cd68, Adgre1, and Il6 gene expression, as well as the mRNA for epididymal Lep and Adipoq, which were significantly elevated in HFD DIO mice [1]. |
| References |
[1]. A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice. PLoS One. 2016 Nov 10;11(11):e0166198. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~125 mg/mL (~264.12 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (4.39 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (4.39 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1130 mL | 10.5648 mL | 21.1296 mL | |
| 5 mM | 0.4226 mL | 2.1130 mL | 4.2259 mL | |
| 10 mM | 0.2113 mL | 1.0565 mL | 2.1130 mL |